Noninvasive tests for liver fibrosis.

Area of Science:

• Hepatology and diagnostic marker development.
• Biomarker research for liver disease assessment.

Background:

• Noninvasive markers are increasingly replacing traditional methods for hepatic fibrosis assessment.
• The extracellular matrix's synthesis and degradation balance is key in fibrosis.
• Artificial intelligence integrates lab tests, biomarkers, and imaging for fibrosis evaluation.

Purpose of the Study:

• To review advancements in noninvasive markers for hepatic fibrosis.
• To highlight the potential of integrated diagnostic approaches.

Main Methods:

• Review of current noninvasive diagnostic techniques for hepatic fibrosis.
• Analysis of artificial intelligence and biomarker integration.
• Exploration of gene and protein analysis in fibrosis detection.

Main Results:

• Noninvasive tests show progress but often fail to detect mild hepatic fibrosis.
• Advanced fibrosis and cirrhosis are more readily identified by current methods.
• Gene and protein analysis show potential for specific patient subgroup identification.

Conclusions:

• A combination of serological, radiological, genetic, and proteomic tests is anticipated for accurate fibrosis assessment.
• Future strategies aim for cost-effective and timely diagnosis of hepatic fibrosis.
• Improved detection of mild fibrosis remains a critical challenge.